Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study. [electronic resource]
Producer: 20090326Description: 161-6 p. digitalISSN:- 1096-8652
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cytarabine -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm
- Female
- Humans
- Idarubicin -- administration & dosage
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Vidarabine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.